Clinical Trial Update: Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma [Phase 1]

View source ↗

Summary

A Phase 1 safety study in adults with mild allergic rhinitis, with or without mild asthma, evaluating a reference endotoxin; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Clinical Center Reference Endotoxin (endotoxin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Mild Allergic Rhinitis, Mild Allergic Rhinitis With Mild Asthma | Phase 1 | Status: TERMINATED